Last reviewed · How we verify
Fish oil emulsion — Competitive Intelligence Brief
phase 3
Nutritional supplement / Lipid emulsion
Nutrition / Critical care / Immunomodulation
Small molecule
Live · refreshed every 30 min
Target snapshot
Fish oil emulsion (Fish oil emulsion) — Centre Hospitalier Universitaire Vaudois. Fish oil emulsion delivers omega-3 polyunsaturated fatty acids (EPA and DHA) that reduce inflammation and modulate immune and metabolic pathways.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fish oil emulsion TARGET | Fish oil emulsion | Centre Hospitalier Universitaire Vaudois | phase 3 | Nutritional supplement / Lipid emulsion |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Nutritional supplement / Lipid emulsion class)
- Centre Hospitalier Universitaire Vaudois · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fish oil emulsion CI watch — RSS
- Fish oil emulsion CI watch — Atom
- Fish oil emulsion CI watch — JSON
- Fish oil emulsion alone — RSS
- Whole Nutritional supplement / Lipid emulsion class — RSS
Cite this brief
Drug Landscape (2026). Fish oil emulsion — Competitive Intelligence Brief. https://druglandscape.com/ci/fish-oil-emulsion. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing